. Codagenix announces promising findings for intranasal COVID vaccine - IOPAC Press "Enter" to skip to content

Governments near agreement on package of amendments to the International Health Regulations (2005)
- All WHO news
In the eighth meeting of the Working Group on Amendments to the International Health Regulations (WGIHR), which was suspended yesterday...
WHO and France convene high-level meeting to defeat meningitis
- All WHO news
<p>Global<strong> </strong>leaders highlight the need to defeat meningitis – a leading cause of disability – at a high-level meeting co-hosted...
WHO reports widespread overuse of antibiotics in patients hospitalized with COVID-19
- All WHO news
<p>New evidence from the World Health Organization (WHO) shows the extensive overuse of antibiotics during COVID-19 pandemic worldwide, which may...

The right to health
- WHO Director-General speeches
Excellencies, ladies and gentlemen, Good afternoon, and thank you for having me. It’s a real honour to be with you...
Closing address at High-Level Action Day, First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Every human being is entitled to breathe clean air. It’s a human right. We are honoured to have the Human...
Opening address at the First WHO Global Conference on Air Pollution and Health
- WHO Director-General speeches
Excellency, second Lady Hajia Samira Bawumia of Ghana, my colleague colleague Dr Taalas, Secretary General of WMO and my sister...

Codagenix announces promising findings for intranasal COVID vaccine

By iopac on October 12, 2023

Earlier this month, the company received a contract from Project NextGen, a federal effort to deliver new treatments and vaccines.

Published in COVID-19

iopac